The World Health Organization is stopping its trial of the hyped drug hydroxychloroquine, it announced Wednesday.
The decision was made on the basis of data from a large, randomized U.K. trial of the drug as well as the data available to the WHO through its own Solidarity trial, said Ana Maria Henao Restrepo, head of the WHO’s research and development group.
The decision to remove the drug from its Solidarity trial came following several events, Restrepo noted. A review of the evidence suggested there was “no apparent beneficial effect of hydroxychloroquine” to treat Covid-19. In addition, the results coming out of the U.K. last Friday indicated that there was no apparent effect on mortality or ventilation during a hospital stay. Finally, there was the Solidarity trial’s own evidence.
This news comes after the WHO paused enrolling patients following findings from a now-retracted study in the Lancet that had indicated that there was an increased risk of heart problems and death in Covid-19 patients who used chloroquine and hydroxychloroquine. The WHO then restarted the trial following a safety review.
In Europe, the hype around the drug originated in France, where a small, non-randomized trial under doctor Didier Raoult claimed to have promising results. U.S. President Donald Trump is also a supporter and has claimed he is taking it to prevent the disease.
"who" - Google News
June 18, 2020 at 12:55AM
https://ift.tt/3eeBSEE
WHO ends hydroxychloroquine study - POLITICO - Politico
"who" - Google News
https://ift.tt/36dvnyn
https://ift.tt/35spnC7
Bagikan Berita Ini
0 Response to "WHO ends hydroxychloroquine study - POLITICO - Politico"
Post a Comment